Cullinan Therapeutics chief scientific officer Jennifer Michaelson reports sale of $49,440 in common shares

CGEM•2026-11-06

Jennifer Michaelson sold 4,000 Cullinan Therapeutics common shares for $49,440 on November 5, 2026, and exercised options for 3,805 shares at $4.30 each.

1. Share transactions

Cullinan Therapeutics Chief Scientific Officer Jennifer Michaelson sold 4,000 common shares at $12.36 each on November 5, 2026. She also exercised stock options for 3,805 common shares at $4.30 each that day. After the transactions, she directly held 158,649 common shares and 75,182 stock options.

Sources

Cullinan Therapeutics chief scientific officer Jennifer Michaelson reports sale of $49,440 in common shares

Sec

Cullinan Therapeutics chief scientific officer Jennifer Michaelson reports sale of $49,440 in common shares

1. Share transactions

Related News

Profusa lowers conversion price floor to $0.20 on NorthView Sponsor I note

Silvia grants chief technology officer 502,513 restricted stock units

RPM International CEO Frank C. Sullivan plans to retire in 12-18 months

Sources

Cullinan Therapeutics chief scientific officer Jennifer Michaelson reports sale of $49,440 in common shares

Silo Pharma closes private placement, expects about $815,000 in net proceeds

Fidelity National Financial presents 20% decline in third-quarter adjusted net earnings to $352 million